Filing Details

Accession Number:
0001181431-12-049904
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-11 17:40:08
Reporting Period:
2012-09-07
Filing Date:
2012-09-11
Accepted Time:
2012-09-11 17:40:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113148 Infinity Pharmaceuticals Inc. INFI Pharmaceutical Preparations (2834) 330655706
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1450996 Beacon Co C/O Ogier House, The Esplanade
St. Helier
Jersey Channel Islands JE4 9WG
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-09-07 5,416,565 $14.50 5,416,565 No 4 P Indirect By Purdue Pharma L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Purdue Pharma L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Purchase Warrants (right to buy) Acquisiton 2009-01-07 500,000 $0.00 500,000 $20.00
Common Stock Stock Purchase Warrants (right to buy) Acquisiton 2009-01-07 1,000,000 $0.00 1,000,000 $30.00
Common Stock Stock Purchase Warrants (right to buy) Acquisiton 2009-01-07 1,500,000 $0.00 1,500,000 $40.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-01-07 2010-07-01 No 4 H Direct
0 2009-01-07 2011-07-01 No 4 H Direct
0 2009-01-07 2012-07-02 No 4 H Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,000,000 Direct
Footnotes
  1. These securities were purchased by Purdue Pharma L.P. pursuant to the Securities Purchase Agreement between the Issuer, Purdue Pharma L.P., Rosebay Medical Company L.P. and the Reporting Person, dated July 17, 2012 (the "Securities Purchase Agreement"). The Reporting Person and Rosebay Medical Company L.P. are the ultimate parents of Purdue Pharma L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
  2. These warrants expired and were not exercised by the holder.